These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36200659)

  • 1.
    Ellis RC; Roberts EK; Grier JT; Fiester SE
    Future Microbiol; 2022 Nov; 17():1345-1347. PubMed ID: 36200659
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes of Acinetobacter baumannii infections in children before and after the COVID-19 pandemic in Zhengzhou, China.
    Li L; Yu Z; Li M; Sun H
    J Infect; 2023 Feb; 86(2):154-225. PubMed ID: 36470411
    [No Abstract]   [Full Text] [Related]  

  • 3. Air dispersal of multidrug-resistant Acinetobacter baumannii: implications for nosocomial transmission during the COVID-19 pandemic.
    Wong SC; Lam GK; Chen JH; Li X; Ip FT; Yuen LL; Chan VW; AuYeung CH; So SY; Ho PL; Yuen KY; Cheng VC
    J Hosp Infect; 2021 Oct; 116():78-86. PubMed ID: 34403765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy to limit multidrug-resistant
    Apisarnthanarak A; Weber DJ
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1517-1518. PubMed ID: 34162455
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.
    Russo A; Gavaruzzi F; Ceccarelli G; Borrazzo C; Oliva A; Alessandri F; Magnanimi E; Pugliese F; Venditti M
    Infection; 2022 Feb; 50(1):83-92. PubMed ID: 34176088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinetobacter baumannii resistant to everything: what should we do?
    Vila J; Pachón J
    Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
    [No Abstract]   [Full Text] [Related]  

  • 7. Co-infection of ST2
    Abdollahi A; Aliramezani A; Salehi M; Norouzi Shadehi M; Ghourchian S; Douraghi M
    BMC Infect Dis; 2021 Sep; 21(1):927. PubMed ID: 34496774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Amplex eazyplex SuperBug Acineto test for direct detection of multi-drug-resistant Acinetobacter baumannii bloodstream infections in high endemicity settings.
    Comini S; Bianco G; Boattini M; Iannaccone M; Casale R; Banche G; Cavallo R; Costa C
    J Hosp Infect; 2021 Nov; 117():179-181. PubMed ID: 34562546
    [No Abstract]   [Full Text] [Related]  

  • 9. High rate of colistin dependence in Acinetobacter baumannii.
    Hong YK; Lee JY; Wi YM; Ko KS
    J Antimicrob Chemother; 2016 Aug; 71(8):2346-8. PubMed ID: 27076109
    [No Abstract]   [Full Text] [Related]  

  • 10. What are the considerations for the treatment of multidrug resistant
    Jantarathaneewat K; Camins B; Apisarnthanarak A
    Expert Opin Pharmacother; 2022 Oct; 23(15):1667-1672. PubMed ID: 36210527
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
    Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.
    Dijkshoorn L; Nemec A; Seifert H
    Nat Rev Microbiol; 2007 Dec; 5(12):939-51. PubMed ID: 18007677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii.
    Apisarnthanarak A; Mundy LM
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):678-9. PubMed ID: 18624670
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively drug-resistant Acinetobacter baumannii.
    Doi Y; Husain S; Potoski BA; McCurry KR; Paterson DL
    Emerg Infect Dis; 2009 Jun; 15(6):980-2. PubMed ID: 19523312
    [No Abstract]   [Full Text] [Related]  

  • 17. Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Cheng J; Yan J; Reyna Z; Slarve M; Lu P; Spellberg B; Luna B
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.
    Hanlon GW
    Lett Appl Microbiol; 2005; 41(5):375-8. PubMed ID: 16238638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency And Clinical Spectrum Of Multidrug Resistant Acinetobacter Baumannii As A Significant Nosocomial Pathogen In Intensive Care Unit Patients.
    Sana F; Hussain A; Hussain W; Zaman G; Abbas MW; Imtiaz A; Satti L
    J Ayub Med Coll Abbottabad; 2021; 33(Suppl 1)(4):S752-S756. PubMed ID: 35077621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal.
    Shrestha S; Tada T; Shrestha B; Kirikae T; Ohara H; Rijal BP; Pokhrel BM; Sherchand JB
    J Nepal Health Res Counc; 2016 May; 14(33):72-76. PubMed ID: 27885285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.